News & Events

News &

TRS4Vision data to be presented at the Uveitis Webinar 30: Glaucoma in uveitis – IUSG (International uveitis study group)

October 07, 2023

We are delighted to announce that Prof. Marc de Smet will present TRS4Vision data at Uveitis – Webinar 30. In his presentation titled ‘Newer Drugs on the Horizon for Uveitis and Glaucoma’, Prof. de Smet will delve into the results of Tarsier’s TRS4Vision phase 3 trial and the relevance of TRS01 (eye drop formulation of dazdotuftide) as a drug candidate for uveitis glaucoma.

Professeur Marc de Smet | Hirslanden Group
Prof. Marc de Smet

For more information, click here.

Investor Relations Tarsier Pharma
[email protected]


Scroll to Top